Konovo
Tal Rosenberg currently serves as Chief Executive Officer at Konovo since September 2024. Prior to this role, Tal held various leadership positions at Datavant from November 2020 to September 2024, including President and GM of Life Sciences, Ecosystem and Public Sector, and President of Emerging Businesses & Partnerships. Tal's extensive experience in the industry includes a tenure at IQVIA from October 2008 to October 2020, where roles encompassed SVP of Global Technology Solutions and VP & GM of Technology Solutions, US. Earlier career highlights include positions at Skila Inc from August 1997 to October 2008, such as VP & GM, Head of Skila Europe. Tal holds an EMBA in Management from NYU Stern School of Business and completed the Professional Service Firm Leader program at the University of Cambridge.
This person is not in any teams
This person is not in any offices
Konovo
Konovo is a global healthcare intelligence company on a mission to transform healthcare research by connecting insights across the life science ecosystem. Originally launched in 2019 as Apollo Intelligence, Konovo was born out of the combined capabilities of three industry-leading healthcare research firms: InCrowd, Survey Healthcare Global (SHG), and GlocalMind. Konovo’s 300+ employees support top global pharmaceutical and healthcare brands, market research agencies, and consultancies by connecting them with custom healthcare audiences worldwide—physicians, KOLs, patients, caregivers, and allied healthcare professionals—through an intelligent platform. Today, Konovo represents the broadest reach of audiences, partners, and data, supporting the generation of deeper and actionable insights in life science industries across the Americas, Europe, and Asia. Konovo is a portfolio company of Frazier Healthcare Partners. For more information about Konovo, please visit our website www.konovo.com